Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jun 28, 2009; 15(24): 2987-2994
Published online Jun 28, 2009. doi: 10.3748/wjg.15.2987
Published online Jun 28, 2009. doi: 10.3748/wjg.15.2987
Figure 2 L-81 ameliorated diabetes.
A: Food intake and (B) water intake of mice fed on a chow diet, with or without the indicated drugs (n = 3 in each group). C: Fasting plasma glucose levels of lean control mice or db/db mice treated with L-81 or rosig before and after a 21 d treatment of the indicated drugs; D: Glucose tolerance of mice treated with the indicated drugs. Mice injected with glucose had their blood glucose level monitored by Onetouch Ultra Blood Glucose Monitoring system. E: Plasma insulin level of db/db mice treated with the indicated drugs for 4 wk; F: Plasma adiponectin level of db/db mice treated with the indicated drugs for 4 wk. aP < 0.05 compared with untreated control.
-
Citation: Au WS, Lu LW, Tam S, Ko OKH, Chow BK, He ML, Ng SS, Yeung CM, Liu CC, Kung HF, Lin MC. Pluronic L-81 ameliorates diabetic symptoms in
db/db mice through transcriptional regulation of microsomal triglyceride transfer protein. World J Gastroenterol 2009; 15(24): 2987-2994 - URL: https://www.wjgnet.com/1007-9327/full/v15/i24/2987.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2987